Wang, Ming
Leng, Xiaochang
Wu, Jiong
Gao, Yuhai
Fiehler, Jens
Siddiqui, Adnan H.
Xiang, Jianping
Koduri, Sravanthi
Wan, Shu
Funding for this research was provided by:
Natural Science Foundation of Zhejiang Province (Y21H090041)
Medical Health Science and Technology Project of Zhejiang Provincial Health Commission (WKJ-ZJ-2014 and 2020KY133, WKJ-ZJ-2014 and 2020KY133)
Key Research and Development Project of Zhejiang Provincial Department of Science and Technology (2021C03105)
Article History
Received: 27 April 2022
Accepted: 10 May 2022
First Online: 30 May 2022
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: MW, BM, JW, RZ, DL, CZ, YG, NW, YL, and SW declare no competing interests. XL, JX—Stock or stock options: ArteryFlow Technology Co., Ltd. JF receives research support from the German Ministry of Science and Education (BMBF), German Ministry of Economy and Innovation (BMWi), German Research Foundation (DFG), European Union (EU), Hamburgische Investitions- and Förderbank (IFB), Medtronic, Microvention, Philips, Stryker; and serves as a consultant for Acandis, Boehringer Ingelheim, Cerenovus, Evasc Neurovascular, MD Clinicals, Medtronic, Medina, Microvention, Penumbra, Route92, Stryker, Transverse Medical; and serves as an Editorial Board member (Associate Editor) of the Journal of NeuroInterventional Surgery. AHS—Consulting fees: Amnis Therapeutics, Apellis Pharmaceuticals, Inc.; Boston Scientific, Canon Medical Systems USA, Inc.; Cardinal Health 200, LLC; Cerebrotech Medical Systems, Inc.; Cerenovus, Cerevatech Medical, Inc.; Cordis, Corindus, Inc.; Endostream Medical, Ltd.; Imperative Care, Integra, IRRAS AB, Medtronic, MicroVention, Minnetronix Neuro, Inc.; Penumbra, Q’Apel Medical, Inc.; Rapid Medical, Serenity Medical, Inc.; Silk Road Medical, StimMed, LLC; Stryker Neurovascular, Three Rivers Medical, Inc.; VasSol, Viz.ai, Inc.; W.L. Gore & Associates. Leadership or fiduciary role in other board, society, committee or advocacy group: Secretary of the Board of the Society of NeuroInterventional Surgery, Chair of the Cerebrovascular Section of the AANS/CNS. Stock or stock options: Adona Medical, Inc.; Amnis Therapeutics, Bend IT Technologies, Ltd.; BlinkTBI, Inc.; Buffalo Technology Partners, Inc.; Cardinal Consultants, LLC; Cerebrotech Medical Systems, Inc.; Cerevatech Medical, Inc.; Cognition Medical, CVAID Ltd., E8, Inc.; Endostream Medical, Ltd.; Imperative Care, Inc.; Instylla, Inc.; International Medical Distribution Partners, Launch NY, Inc.; NeuroRadial Technologies, Inc.; Neurotechnology Investors, Neurovascular Diagnostics, Inc.; PerFlow Medical, Ltd.; Q’Apel Medical, Inc.; QAS.ai, Inc.; Radical Catheter Technologies, Inc.; Rebound Therapeutics Corp. (Purchased 2019 by Integra Lifesciences, Corp); Rist Neurovascular, Inc. (Purchased 2020 by Medtronic); Sense Diagnostics, Inc.; Serenity Medical, Inc.; Silk Road Medical, Inc.; SongBird Therapy, Spinnaker Medical, Inc.; StimMed, LLC; Synchron, Inc.; Three Rivers Medical, Inc.; Truvic Medical, Inc.; Tulavi Therapeutics, Inc.; Vastrax, LLC; VICIS, Inc.; Viseon, Inc. Other financial or non-financial interests: National PI/Steering Committees: Cerenovus EXCELLENT and ARISE II Trial; Medtronic SWIFT PRIME, VANTAGE, EMBOLISE and SWIFT DIRECT Trials; MicroVention FRED Trial & CONFIDENCE Study; MUSC POSITIVE Trial; Penumbra 3D Separator Trial; COMPASS Trial; INVEST Trial; MIVI neuroscience EVAQ Trial; Rapid Medical SUCCESS Trial; InspireMD C-GUARDIANS IDE Pivotal Trial.